Sean Harper — Westlake Village BioPartners

January 20, 2021

Pre-Seed
Seed
Series A
With their recently raised $500M, Westlake Village BioPartners is catalyzing the LA biotech ecosystem.

Sean Harper, former Head of R&D at Amgen, tells us about his focus on therapeutics to improve human lives and starting Westlake with Beth Seidenberg.

Full transcript

Hello and welcome to the LA venture podcast. This is Minnie Ingersoll host of the podcast and partner at TenOneTen. TenOneTen is a seed stage fund here in LA. All opinions expressed on this show by me and my guests are solely our own.    

Today's episode of LA venture is sponsored by SaaSSoft offering customized software development for your startups needs. SaaSsoft is a group of top software developers all based here in Los Angeles. If you are looking to build a new product from scratch, or if you're a founder that needs help accelerating product development, SaaSsoft can help.

With SaaSsoft, you'll get the personal attention you need to make your product a reality. In 2021, head to SaaSsoft.com, S a a S S O F T for a free consultation. 

I'm excited for my discussion with Sean Harper today, Sean is a managing director at Westlake Village BioPartners. Westlake Bio recently raised a $500 million fund II, to continue their work funding transformative life science companies. Sean founded Westlake at the end of 2018 with Beth Seidenberg after leaving his role as head of R and D at Amgen.

Sean, thanks for coming on the show. 

Thanks for having me.

 Of course, I'd love to start with the basics. Uh, maybe you could tell me about Westlake bio and what sort of companies you're funding and what stage those countries these are.